stella
beta
5 fr Ultrahypofractionated WBI and SIB for Breast Cancer With Unfavorable Characteristics — Stella
Home
/
Breast Cancer
/
5 fr Ultrahypofractionated WBI and SIB for Breast Cancer With Unfavorable Characteristics
View on ClinicalTrials.gov
Recruiting
Back to Breast Cancer trials
5 fr Ultrahypofractionated WBI and SIB for Breast Cancer With Unfavorable Characteristics
Not a traditional drug trial — this study doesn't follow the standard phase structure.
Trial locations
(1 site)
Italy
IRCCS San Raffaele Scientific Institute, Milan